Sebastián Jaurretche

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Venues

Global health, epidemiology and genomics

Healthcare (Basel, Switzerland)

Case reports in nephrology

International journal of chronic diseases

Instituto Universitario Italiano de Rosario (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Instituto Universitario Italiano de Rosario Mar 23 2017

Argentina

PHD :: Biophysics and Human Physiology

Publications

Sebastián Jaurretche, Santiago Alonso, Mónica Calvo, Sebastián Fernandez, Heber Figueredo, Beatriz Galli, Ivanna Marin, Andrés Martinez, Silvia Mattausch, Fernando Perretta, Juan Politei, Juan Ignacio Rolon, Esteban Calabrese
Baseline Characteristics of Fabry Disease "Amenable" Migalastat Patients in Argentinian Cohort. Global health, epidemiology and genomics 2024 (2024)
Sebastián Jaurretche, Santiago Alonso, Mónica Calvo, Sebastián Fernandez, Heber Figueredo, Beatriz Galli, Ivanna Marin, Andrés Martinez, Silvia Mattausch, Fernando Perretta, Juan Politei, Juan Ignacio Rolon, Esteban Calabrese
Baseline Characteristics of Fabry Disease "Amenable" Migalastat Patients in Argentinian Cohort. Global health, epidemiology and genomics 2024 (2024)
Sebastián Jaurretche, Santiago Alonso, Mónica Calvo, Sebastián Fernandez, Heber Figueredo, Beatriz Galli, Ivanna Marin, Andrés Martinez, Silvia Mattausch, Fernando Perretta, Juan Politei, Juan Ignacio Rolon, Esteban Calabrese
Baseline Characteristics of Fabry Disease "Amenable" Migalastat Patients in Argentinian Cohort. Global health, epidemiology and genomics 2024 (2024)
Sebastián Jaurretche, Santiago Alonso, Mónica Calvo, Sebastián Fernandez, Heber Figueredo, Beatriz Galli, Ivanna Marin, Andrés Martinez, Silvia Mattausch, Fernando Perretta, Juan Politei, Juan Ignacio Rolon, Esteban Calabrese
Baseline Characteristics of Fabry Disease "Amenable" Migalastat Patients in Argentinian Cohort. Global health, epidemiology and genomics 2024 (2024)
Fernando Perretta, Sebastián Jaurretche
Fabry Disease: Switch from Enzyme Replacement Therapy to Oral Chaperone Migalastat: What Do We Know Today? Healthcare (Basel, Switzerland) 11 (4) (2023)
Fernando Perretta, Sebastián Jaurretche
Fabry Disease: Switch from Enzyme Replacement Therapy to Oral Chaperone Migalastat: What Do We Know Today? Healthcare (Basel, Switzerland) 11 (4) (2023)
Fernando Perretta, Sebastián Jaurretche
Fabry Disease: Switch from Enzyme Replacement Therapy to Oral Chaperone Migalastat: What Do We Know Today? Healthcare (Basel, Switzerland) 11 (4) (2023)
Sebastián Jaurretche, Hernan Conde, Ana Gonzalez Schain, Franco Ruiz, Maria Victoria Sgro, Graciela Venera
Biomarkers for Monitoring Renal Damage Due to Fabry Disease in Patients Treated with Migalastat: A Review for Nephrologists. Genes 13 (10) (2022)
Sebastián Jaurretche, Germán R Perez, Graciela Venera
High Lyso-Gb3 Plasma Levels Associated with Decreased miR-29 and miR-200 Urinary Excretion in Young Non-Albuminuric Male Patient with Classic Fabry Disease. Case reports in nephrology 2019 (2019)
Sebastián Jaurretche, Germán Perez, Norberto Antongiovanni, Fernando Perretta, Graciela Venera
Variables Associated with a Urinary MicroRNAs Excretion Profile Indicative of Renal Fibrosis in Fabry Disease Patients. International journal of chronic diseases 2019 (2019)

Sebastián Jaurretche.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sebastián Jaurretche